A double-blind cross-over clinical valuation of metoclopramide and a combination of haloperidol and isopropamide iodide in gastroenterology.
D000293:Adolescent; D000328:Adult; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003108:Colonic Diseases / Q000188:drug therapy; D003248:Constipation / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D003967:Diarrhea / Q000188:drug therapy; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011183:Postoperative Complications / Q000188:drug therapy; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy
D000932:Antiemetics; D010919:Placebos; D000644:Quaternary Ammonium Compounds; D006220:Haloperidol